{ "id": "mmr-measles", "slug": "mmr", "topic": "Vaccines", "tag": "MMR & measles", "revision": "vaccine-2026-10-15", "locale": "en", "assessment": "Source-grounded explanation · research draft", "title": "Measles vaccines are safe and effective", "signLines": [ "Measles vaccines", "are safe", "and effective" ], "question": "How well does MMR protect against measles, and what are the risks?", "summary": "Measles vaccination prevents a highly contagious disease that can cause serious illness and death. MMR is highly effective and does not cause autism. Vitamin A can support measles care, but it does not replace vaccination. Serious side effects are rare.", "scope": "", "geographicScope": { "kind": "global", "countryCodes": [], "jurisdictionCodes": [], "note": "Evidence and jurisdiction limits are stated beside the relevant claims." }, "evidence": [ { "id": "measles-protection", "heading": "Vaccination prevents measles", "text": "The Cochrane review estimated about 95% measles protection after one MMR dose in children. Protection is high, not perfect. Measles can cause pneumonia, brain inflammation and death. Live MMR is not suitable during pregnancy or for some people with severe immune suppression; individual eligibility needs medical assessment.", "sources": [ 1, 2 ], "detailTopics": [ "vaccine-schedule" ], "sourceIds": [ "vaccine-update-m1", "vaccine-update-m3" ] }, { "id": "mmr-side-effects", "heading": "Safety and side effects", "text": "MMR can cause fever. CDC estimates roughly one fever-related seizure per 3,000–4,000 MMR recipients. Low platelets and severe allergy are rare. MMRV, which also covers chickenpox, has a different first-dose seizure-risk comparison from MMR plus a separate chickenpox vaccine. These numbers should not be merged.", "sources": [ 3 ], "detailTopics": [ "vaccine-ingredients" ], "quickLink": "Safety and side effects", "sourceIds": [ "vaccine-update-m2" ] }, { "id": "mmr-autism", "heading": "MMR does not cause autism", "text": "The review’s autism analysis included two observational studies totaling 1,194,764 children and found no increased risk. That is the autism sample, not the total population across every outcome in the review.", "sources": [ 1, 4 ], "detailTopics": [ "vaccines-autism" ], "sourceIds": [ "vaccine-update-m1", "vaccine-update-a1" ] }, { "id": "vitamin-a", "heading": "Vitamin A supports care, not a replacement for vaccination", "text": "Clinicians can use vitamin A in measles care and to correct deficiency. Community supplementation studies in particular settings found low-certainty evidence of fewer measles cases. That does not show that high-dose supplements replace MMR in well-nourished children. Excess vitamin A can harm; treatment needs medical supervision.", "sources": [ 2, 5 ], "detailTopics": [], "sourceIds": [ "vaccine-update-m3", "vaccine-update-m4" ] }, { "id": "immune-memory", "heading": "Surviving measles has a cost", "text": "Measles can erase parts of the antibody memory built against other infections. The study measured the range of antibodies measured—not the percentage of a child’s entire immune system destroyed. Avoiding measles avoids this damage as well as the initial illness.", "sources": [ 6 ], "detailTopics": [], "sourceIds": [ "vaccine-update-m5" ] }, { "id": "outbreak-strains", "heading": "Outbreak viruses can be identified", "text": "In the 2025 Kansas, New Mexico and Texas investigation, all 208 genotyped outbreak specimens were wild genotype D8. Texas research published in 2026 also identified D8 from the 2025 outbreak. These were not vaccine-strain outbreaks. Finding vaccine RNA after vaccination and identifying contagious wild-type measles are different questions.", "sources": [ 7, 8 ], "detailTopics": [], "sourceIds": [ "vaccine-update-m6", "vaccine-update-m7" ] } ], "takeaway": "Measles vaccination prevents a highly contagious disease that can cause serious illness and death.", "limits": [ "The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance." ], "contextTitle": "", "contextIntro": "", "detail": "", "sources": [ { "id": "vaccine-update-m1", "title": "Vaccines for measles, mumps, rubella, and varicella in children", "publisher": "Cochrane, 2021", "url": "https://www.cochrane.org/evidence/CD004407_does-measles-mumps-rubella-and-varicella-mmrv-vaccine-protect-children-and-does-it-cause-harmful", "readerBlurb": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals.", "limit": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." }, "publicationTitle": "Vaccines for measles, mumps, rubella, and varicella in children", "archiveDate": "2026-10-14", "supports": [ "Vaccination prevents measles", "MMR does not cause autism" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." ], "limitationsPublic": [ "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." ] }, { "id": "vaccine-update-m3", "title": "Clinical Overview of Measles", "publisher": "CDC", "url": "https://www.cdc.gov/measles/hcp/clinical-overview/", "readerBlurb": "Explains complications, medical care and the supervised role of vitamin A.", "limit": "Explains complications, medical care and the supervised role of vitamin A.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Explains complications, medical care and the supervised role of vitamin A." }, "publicationTitle": "Clinical Overview of Measles", "archiveDate": "2026-10-14", "supports": [ "Vaccination prevents measles", "Vitamin A supports care, not a replacement for vaccination" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Explains complications, medical care and the supervised role of vitamin A." ], "limitationsPublic": [ "Explains complications, medical care and the supervised role of vitamin A." ] }, { "id": "vaccine-update-m2", "title": "Measles, Mumps, Rubella (MMR) Vaccine Safety", "publisher": "CDC", "url": "https://www.cdc.gov/vaccine-safety/vaccines/mmr.html", "readerBlurb": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison.", "limit": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." }, "publicationTitle": "Measles, Mumps, Rubella (MMR) Vaccine Safety", "archiveDate": "2026-10-14", "supports": [ "Safety and side effects" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." ], "limitationsPublic": [ "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." ] }, { "id": "vaccine-update-a1", "title": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism", "publisher": "WHO, 2025", "url": "https://www.who.int/news/item/11-12-2025-statement-gacvs-vaccines-autism", "readerBlurb": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.", "limit": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." }, "publicationTitle": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism", "archiveDate": "2026-10-14", "supports": [ "MMR does not cause autism" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." ], "limitationsPublic": [ "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." ] }, { "id": "vaccine-update-m4", "title": "Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age", "publisher": "Cochrane, 2022", "url": "https://pubmed.ncbi.nlm.nih.gov/35294044/", "readerBlurb": "Community supplementation evidence, largely from lower-income settings; not a test of replacing MMR in well-nourished children.", "limit": "Community supplementation evidence, largely from lower-income settings; not a test of replacing MMR in well-nourished children.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Community supplementation evidence, largely from lower-income settings; not a test of replacing MMR in well-nourished children." }, "publicationTitle": "Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age", "archiveDate": "2026-10-14", "supports": [ "Vitamin A supports care, not a replacement for vaccination" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Community supplementation evidence, largely from lower-income settings; not a test of replacing MMR in well-nourished children." ], "limitationsPublic": [ "Community supplementation evidence, largely from lower-income settings; not a test of replacing MMR in well-nourished children." ] }, { "id": "vaccine-update-m5", "title": "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens", "publisher": "Science, 2019", "url": "https://pubmed.ncbi.nlm.nih.gov/31672891/", "readerBlurb": "Measures loss of parts of antibody memory after measles, not a percentage of the whole immune system.", "limit": "Measures loss of parts of antibody memory after measles, not a percentage of the whole immune system.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Measures loss of parts of antibody memory after measles, not a percentage of the whole immune system." }, "publicationTitle": "Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens", "archiveDate": "2026-10-14", "supports": [ "Surviving measles has a cost" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Measures loss of parts of antibody memory after measles, not a percentage of the whole immune system." ], "limitationsPublic": [ "Measures loss of parts of antibody memory after measles, not a percentage of the whole immune system." ] }, { "id": "vaccine-update-m6", "title": "Measles Update — United States, January 1–April 17, 2025", "publisher": "CDC MMWR, 2025", "url": "https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm", "readerBlurb": "Genotyping distinguishes wild virus from vaccine strains; not every US sample had the same wild genotype.", "limit": "Genotyping distinguishes wild virus from vaccine strains; not every US sample had the same wild genotype.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." }, "publicationTitle": "Measles Update — United States, January 1–April 17, 2025", "archiveDate": "2026-10-14", "supports": [ "Outbreak viruses can be identified" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Genotyping distinguishes wild virus from vaccine strains; not every US sample had the same wild genotype." ], "limitationsPublic": [ "Genotyping distinguishes wild virus from vaccine strains; not every US sample had the same wild genotype." ] }, { "id": "vaccine-update-m7", "title": "Whole-Genome Sequencing of Measles Virus from 2025 Outbreak, Texas, USA", "publisher": "Emerging Infectious Diseases, 2026", "url": "https://wwwnc.cdc.gov/eid/article/32/10/26-0494_article", "readerBlurb": "Published in 2026 about the 2025 Texas outbreak; sequencing does not establish every transmission direction.", "limit": "Published in 2026 about the 2025 Texas outbreak; sequencing does not establish every transmission direction.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." }, "publicationTitle": "Whole-Genome Sequencing of Measles Virus from 2025 Outbreak, Texas, USA", "archiveDate": "2026-10-14", "supports": [ "Outbreak viruses can be identified" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Published in 2026 about the 2025 Texas outbreak; sequencing does not establish every transmission direction." ], "limitationsPublic": [ "Published in 2026 about the 2025 Texas outbreak; sequencing does not establish every transmission direction." ] } ], "dossier": "vaccine-narratives-major-2026-10-14.md", "reviewNeeds": "Independent clinical/editorial approval remains pending; no personalized schedule.", "updateTriggers": "New studies, corrected sources, regulatory safety signals and changed local recommendations.", "related": [ { "slug": "vaccines-autism", "label": "Vaccines don't cause autism", "reason": "See the broader studies." }, { "slug": "vaccine-schedule", "label": "Childhood schedules", "reason": "Understand timing and protection." }, { "slug": "vaccine-ingredients", "label": "Vaccine ingredients", "reason": "Check the actual formulation." } ], "researchDate": "2026-10-14", "questionsHeading": "Find the answer you need", "questions": [ { "slug": "vaccines-autism", "label": "Do vaccines cause autism?", "description": "What large studies found, including in children with an autistic sibling." }, { "slug": "vaccine-amplification", "label": "Who helped spread the vaccine debate?", "description": "What one historical Twitter study can tell us." } ], "supplementalDossiers": [ { "file": "foreign_influence_campaigns_review.md", "label": "Download the historical amplification review" }, { "file": "vaccine_evidence_dossier.txt", "label": "Earlier supporting research" } ], "shareContext": "Two doses give strong measles protection. Side effects and who can receive the vaccine still matter.", "socialContext": "MMR gives strong measles protection. Side effects and who can receive MMR still matter.", "copyReviewedAt": "2026-10-15", "readerCopyEdition": "vaccine-clarity-2026-10-15", "citationDesignEdition": "publication-first-1", "assetDesignEdition": "space-first-1", "keyPoints": [ { "text": "A major evidence review found about 95% protection against measles after one dose.", "sources": [ 1 ] }, { "text": "MMR studies including more than a million children found no increased autism risk.", "sources": [ 1 ] }, { "text": "Preventing measles also avoids its damage to immune memory.", "sources": [ 6 ] } ], "headline": { "text": "Measles vaccines are safe and effective", "revision": 1, "status": "draft", "sourceMessageId": null, "approvedAt": null, "authority": "Existing owner decisions recorded in AGENTS/D39; unavailable message IDs are not invented." }, "language": "en", "jurisdiction": { "kind": "global", "countryCodes": [], "jurisdictionCodes": [], "note": "Evidence and jurisdiction limits are stated beside the relevant claims." }, "claimScope": "", "research": { "dossierRef": "docs/research/vaccine-narratives-major-2026-10-14.md", "reviewedAt": "2026-10-14", "reviewDue": "New studies, corrected sources, regulatory safety signals and changed local recommendations.", "contraryEvidenceConsidered": [], "status": "research draft; editorial/context review separate" }, "status": "researched draft preview", "realWorldClaimReviewed": false, "clinicalEditorialApproved": false }